Highlights and Quick Summary
- Net Debt/EBITDA for the quarter ending August 31, 2022 was 26.65 (a 165.26% increase compared to previous quarter)
- Year-over-year quarterly Net Debt/EBITDA increased by 206.12%
- Annual Net Debt/EBITDA for 2022 was 5.39 (a 147.97% increase from previous year)
- Annual Net Debt/EBITDA for 2021 was 2.17 (a -895.06% decrease from previous year)
- Annual Net Debt/EBITDA for 2020 was -0.27 (a 905.51% increase from previous year)
Visit stockrow.com/OGI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.
Historical Net Debt/EBITDA of Organigram Holdings Inc.Most recent Net Debt/EBITDAof OGI including historical data for past 10 years.
Interactive Chart of Net Debt/EBITDA of Organigram Holdings Inc.
Organigram Holdings Inc. Net Debt/EBITDA for the past 10 Years (both Annual and Quarterly)
Business Profile of Organigram Holdings Inc.
Industry: Drug Manufacturers Specialty & Generic